[go: up one dir, main page]

WO2010119997A1 - 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도 - Google Patents

형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도 Download PDF

Info

Publication number
WO2010119997A1
WO2010119997A1 PCT/KR2009/001918 KR2009001918W WO2010119997A1 WO 2010119997 A1 WO2010119997 A1 WO 2010119997A1 KR 2009001918 W KR2009001918 W KR 2009001918W WO 2010119997 A1 WO2010119997 A1 WO 2010119997A1
Authority
WO
WIPO (PCT)
Prior art keywords
tgf
peptide
present
growth factor
transforming growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/001918
Other languages
English (en)
French (fr)
Inventor
정용지
김영덕
김은미
최정진
최준영
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caregen Co Ltd
Original Assignee
Caregen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caregen Co Ltd filed Critical Caregen Co Ltd
Priority to CN200980159838.2A priority Critical patent/CN102498128B/zh
Priority to JP2012505791A priority patent/JP5611322B2/ja
Priority to US13/264,290 priority patent/US8691195B2/en
Priority to EP09843373.3A priority patent/EP2420511B1/en
Publication of WO2010119997A1 publication Critical patent/WO2010119997A1/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 특정 아미노산 서열을 포함하는 TGF-β(transforming growth factor-beta)-미미킹 펩타이드 및 이를 포함하는 TGF-β-유효성(TGF-β-effective)의 질환 또는 상태(conditions)의 예방 또는 치료용 조성물에 관한 것이다. 본 발명의 펩타이드는 인간 TGF-β로부터 유래된 것으로서, 천연의 인간 TGF-β와 유사한 기능 또는 작용을 한다. 본 발명의 펩타이드는 천연 TGF-β 보다 안정성이 우수하고 천연 TGF-β의 큰 분자량에 의한 문제점을 개선할 수 있다. 본 발명의 펩타이드는 TGF-β가 적용되는 다양한 질환 또는 상태의 치료 또는 개선에 이용될 수 있으며, 특히 피부 미백 및 주름개선에 대하여 탁월한 효능을 발휘한다.
PCT/KR2009/001918 2009-04-14 2009-04-14 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도 Ceased WO2010119997A1 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN200980159838.2A CN102498128B (zh) 2009-04-14 2009-04-14 具有转化生长因子的活性的肽及其用途
JP2012505791A JP5611322B2 (ja) 2009-04-14 2009-04-14 形質転換成長因子の活性を有するペプチド及びその用途
US13/264,290 US8691195B2 (en) 2009-04-14 2009-04-14 Peptide having activity of transforming growth factor and production method therefor
EP09843373.3A EP2420511B1 (en) 2009-04-14 2009-04-14 Peptide having activity of transforming growth factor and production method therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090032052A KR101001156B1 (ko) 2009-04-14 2009-04-14 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도
KR10-2009-0032052 2009-04-14

Publications (1)

Publication Number Publication Date
WO2010119997A1 true WO2010119997A1 (ko) 2010-10-21

Family

ID=41691980

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/001918 Ceased WO2010119997A1 (ko) 2009-04-14 2009-04-14 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도

Country Status (6)

Country Link
US (1) US8691195B2 (ko)
EP (1) EP2420511B1 (ko)
JP (1) JP5611322B2 (ko)
KR (1) KR101001156B1 (ko)
CN (1) CN102498128B (ko)
WO (1) WO2010119997A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014109417A1 (ko) * 2013-01-08 2014-07-17 (주)노바셀테크놀로지 콜라겐 합성능이 있는 신규 펩타이드 및 그의 용도
US9521655B2 (en) * 2013-07-30 2016-12-13 Qualcomm Incorporated Method and apparatus for avoiding power scaling in uplink data transmission
WO2015154078A1 (en) * 2014-04-04 2015-10-08 President And Fellows Of Harvard College Click-crosslinked hydrogels and methods of use
KR101841742B1 (ko) * 2015-12-18 2018-03-27 (주)케어젠 피부 미백 활성을 갖는 펩타이드 및 이의 용도
CN109152718B (zh) * 2017-04-27 2021-08-06 凯尔格恩有限公司 具有皮肤美白活性的肽及其用途

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436228A (en) * 1990-12-12 1995-07-25 Postlethwaite; Arnold E. Chemotactic wound healing peptides
US5658883A (en) * 1993-01-26 1997-08-19 Celtrix Pharmaceuticals, Inc. Biologically active TGF-β1 peptides
US5780436A (en) 1995-05-01 1998-07-14 The Regents Of The University Of California Peptide compositions with growth factor-like activity
WO2000002916A2 (en) * 1998-07-10 2000-01-20 The Regents Of The University Of California PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY
US6428579B1 (en) * 1998-07-01 2002-08-06 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
WO2004091370A2 (en) * 2003-04-10 2004-10-28 The Trustees Of Boston University Method for stimulating angiogenesis and wound healing
KR20080094296A (ko) * 2007-04-19 2008-10-23 (주)케어젠 Ｔｇｆｐ－ｃａｐ 펩타이드 및 그의 용도
KR20090132911A (ko) * 2008-06-23 2009-12-31 (주)케어젠 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도
KR20090132815A (ko) * 2008-06-23 2009-12-31 (주)케어젠 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192242A1 (en) * 1995-10-11 2005-09-01 Neal Zane C. Therapeutic fusion protein transgenes
US6500920B1 (en) * 1997-06-19 2002-12-31 St. Louis University Inhibitor of transforming growth factor β and A method of inhibiting the biological effects of transforming growth factor
US7723473B2 (en) * 1997-06-19 2010-05-25 St. Louis University Peptide antagonists of TGF-beta family members and therapeutic uses thereof
WO2003093293A2 (en) * 2002-04-29 2003-11-13 Saint Louis University Peptide antagonists of tgf-beta family members and therapeutic uses thereof
US8110655B2 (en) * 2006-11-13 2012-02-07 Auxagen, Inc. Method to promote hair growth and/or delay or treat hair loss by administering a TGF-β antagonist or inhibitor
GB0718843D0 (en) * 2007-09-26 2007-11-07 Cancer Rec Tech Ltd Materials and methods relating to modifying the binding of antibodies

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436228A (en) * 1990-12-12 1995-07-25 Postlethwaite; Arnold E. Chemotactic wound healing peptides
US5658883A (en) * 1993-01-26 1997-08-19 Celtrix Pharmaceuticals, Inc. Biologically active TGF-β1 peptides
US5780436A (en) 1995-05-01 1998-07-14 The Regents Of The University Of California Peptide compositions with growth factor-like activity
US20020010134A1 (en) 1995-05-01 2002-01-24 Rajendra S. Bhatnagar Peptide compositions mimicking tgf-beta activity
US6428579B1 (en) * 1998-07-01 2002-08-06 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
WO2000002916A2 (en) * 1998-07-10 2000-01-20 The Regents Of The University Of California PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY
WO2004091370A2 (en) * 2003-04-10 2004-10-28 The Trustees Of Boston University Method for stimulating angiogenesis and wound healing
KR20080094296A (ko) * 2007-04-19 2008-10-23 (주)케어젠 Ｔｇｆｐ－ｃａｐ 펩타이드 및 그의 용도
KR20090132911A (ko) * 2008-06-23 2009-12-31 (주)케어젠 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도
KR20090132815A (ko) * 2008-06-23 2009-12-31 (주)케어젠 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도

Non-Patent Citations (32)

* Cited by examiner, † Cited by third party
Title
"Remington's Pharmaceutical Sciences", 1995
ASSIOAN ET AL., J. BIOL. CHEM., vol. 258, 1983, pages 7155 - 7160
ASSOIAN ET AL., J. BIOL. CHEM., vol. 258, 1983, pages 7155 - 7160
CATE ET AL., CELL, vol. 45, 1986, pages 685 - 698
CHEIFETZ ET AL., CELL, vol. 48, 1987, pages 409 - 415
CHILDS ET AL., PROC. NATL. ACAD SCI. USA, vol. 79, 1982, pages 5312 - 5316
DERYNCK ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 4377 - 4379
DERYNCK ET AL., NATURE, vol. 316, 1985, pages 701 - 705
FROLIK ET AL., J. BIOL. CHEM., vol. 260, 1984, pages 10995 - 11000
FROLIK ET AL., NATURE, vol. 325, 1983, pages 81 - 84
FROLIK ET AL., PROC. NATL. ACAD SCI. USA, vol. 80, 1983, pages 3676 - 3680
IKEDA ET AL., BIOCHEMISTRY, vol. 26, 1987, pages 2406 - 2410
MASON ET AL., NATURE, vol. 318, 1985, pages 659 - 663
MERRIFIELD, J. AMER. CHEM. SOC., vol. 85, 1963, pages 2149 - 54
PADGETT ET AL., NATURE, vol. 325, 1987, pages 81 - 84
RIZZINO, CANCER RES., vol. 48, 1988, pages 4266
ROBERTS ET AL., BIOCHEMISTRY, vol. 22, 1983, pages 5692 - 5698
ROBERTS ET AL., NATURE, vol. 295, 1982, pages 417 - 419
ROBERTS ET AL., PROC. NATL. ACAD SCI USA, vol. 82, 1985, pages 119 - 123
ROBERTS ET AL., PROC. NATL. ACAD. SCI. USA, vol. 78, 1981, pages 5339 - 5343
SCUDIERO, D. A. ET AL., CANCER RES., vol. 48, 1988, pages 4827 - 4833
See also references of EP2420511A4 *
SEYEDIN ET AL., J. BIOL. CHEM, vol. 262, 1987, pages 1946 - 1949
SEYEDIN ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 5693 - 5695
SEYEDIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 119 - 123
SHARPLES ET AL., DNA, vol. 6, 1987, pages 239 - 244
SPON ET AL., SCIENCE, vol. 232, 1986, pages 534
STEWART ET AL.: "Solid Phase Peptide Synthesis", 1984, PIERCE CHEM. CO., pages: 111
TUCKER ET AL., CANCER RES., vol. 43, 1983, pages 1518 - 1586
TUCKER ET AL., SCIENCE, vol. 226, 1984, pages 705 - 707
TWARDZIK ET AL., J. CELL BIOCHEM., vol. 28, 1985, pages 289 - 297
WRANN ET AL., EMBO J, vol. 6, 1987, pages 1633 - 1636

Also Published As

Publication number Publication date
CN102498128B (zh) 2015-02-18
US8691195B2 (en) 2014-04-08
EP2420511A1 (en) 2012-02-22
CN102498128A (zh) 2012-06-13
JP2012523453A (ja) 2012-10-04
US20120114577A1 (en) 2012-05-10
KR101001156B1 (ko) 2010-12-15
EP2420511A4 (en) 2012-09-12
KR20090133068A (ko) 2009-12-31
JP5611322B2 (ja) 2014-10-22
EP2420511B1 (en) 2017-04-05

Similar Documents

Publication Publication Date Title
WO2010085039A2 (ko) 노긴―유래 펩타이드 및 그의 용도
WO2009125925A3 (ko) 성장인자―미미킹 펩타이드 및 그의 용도
WO2009101503A3 (fr) Utilisation de substances actives naturelles dans des compositions cosmétiques ou thérapeutiques
WO2010095118A3 (en) A cosmetic treatment method including the projection of an image onto the zone to be treated
WO2011064402A3 (fr) Extrait de graines d'acacia macrostachya et compositions le comprenant
WO2009080306A8 (en) Anti-dandruff compositions containing peptides
WO2010024608A3 (ko) 콜라겐 펩티드를 함유하는 피부미용 개선용 조성물
EP4349360A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2007136679A3 (en) Targeting vegf-b regulation of fatty acid transporters to modulate human diseases
WO2012065782A3 (de) Kollagenhydrolysat für die verwendung zur verbesserung der gesundheit der menschlichen haut, haare und/oder nägel
WO2010130830A3 (en) Anti-sclerostin vhh and their use for treating bone diseases
WO2012007978A3 (en) Fermented soya based mixture comprising isoflavones- aglicones, equol and lunasil, process for the preparation and uses thereof in food, medical and cosmetic fields
NZ593771A (en) Cyclosporine compositions for enhancing nail growth
WO2008082736A3 (en) Compositions and methods of their use for improving the condition and appearance of skin
WO2011119009A3 (en) Peptides for promoting angiogenesis and an use thereof
FR2969494B1 (fr) Extrait de parties aeriennes de gynandropsis gynandra ou cleome gynandra et compositions cosmetiques, dermatologiques le comprenant
WO2010119997A1 (ko) 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도
WO2010049011A3 (de) Wirkstoffkombination zur behandlung reifer haut ii
WO2012161497A3 (ko) 보습능이 우수한 펩타이드 유도체 및 이의 용도
WO2010008219A3 (ko) 지방조직 유래 다분화능 줄기세포의 배양물 및 그 추출 단백질을 함유한 화장료용 조성물
WO2011075606A3 (en) Hyperglycosylated polypeptide variants and methods of use
WO2011136573A3 (ko) 비만 치료 및 항산화 활성을 갖는 효모 가수분해물
PH12015502005B1 (en) New stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy
WO2010081800A3 (en) Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980159838.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09843373

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012505791

Country of ref document: JP

REEP Request for entry into the european phase

Ref document number: 2009843373

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2009843373

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13264290

Country of ref document: US